Mineralys Therapeutics (MLYS) Preferred Shares Issued (2022)

Mineralys Therapeutics has disclosed Preferred Shares Issued across 1 years of filings, most recently posting -$105.7 million for Q4 2022.

• Preferred Shares Issued for Q4 2022 came in at -$105.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was -$105.7 million (changed N/A YoY), and the FY2022 annual result was $12.0 million, changed N/A from the prior year.
• Preferred Shares Issued came in at -$105.7 million for Q4 2022 at Mineralys Therapeutics, down from $105.7 million in the prior quarter.
• In the past five years, Preferred Shares Issued ranged from a high of $105.7 million in Q3 2022 to a low of -$105.7 million in Q4 2022.